Metabolic effects of 2 days of strict bed rest

Endocrine Practice

Volumn 14, Issue 5, 2008, Pages 564-569

  Duran Valdez, Elizabeth ^a   De Serna, Daniela Gonzalez ^a   Schneider, Suzanne ^a   Amorim, Fabiano ^a   Burge, Mark ^a   Schade, David S ^a  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; C PEPTIDE; C REACTIVE PROTEIN; FIBRINOGEN; GLUCOSE; HEMOGLOBIN A1C; INSULIN; INTERLEUKIN 6; PLASMINOGEN ACTIVATOR INHIBITOR 1;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; BED REST; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC PATIENT; DIET RESTRICTION; FEMALE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HOSPITAL PATIENT; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; MALE; MOBILIZATION; NON INSULIN DEPENDENT DIABETES MELLITUS; PILOT STUDY; PROTEIN BLOOD LEVEL; QUANTITATIVE ANALYSIS; RISK FACTOR; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CROSSOVER PROCEDURE; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGED; BED REST; BLOOD GLUCOSE; C-PEPTIDE; CROSS-OVER STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INSULIN; INSULIN RESISTANCE; MALE; MIDDLE AGED; PILOT PROJECTS; YOUNG ADULT;

EID: 58149466269     PISSN: 1530891X     EISSN: None     Source Type: Journal    
DOI: 10.4158/EP.14.5.564     Document Type: Article

References (30)

1. Biolo G, Ciocchi B, Lebenstedt M, et al. Short-term bed rest impairs amino acid-induced protein anabolism in humans. J Physiol. 2004;558(pt 2):381-388.
2. Smorawiński J, Kaciuba-Uścilko H, Nazar K, et al. Effects of three-day bed rest on metabolic, hormonal and circulatory response to an oral glucose load in endurance or strength trained athletes and untrained subjects. J Physiol Pharmacol. 2000;51:279-289.
3. Smorawinski J, Kaciuba-Uscilko H, Nazar K, Kaminska E, Korszun P, Greenleaf JE. Comparison of changes in glucose tolerance and insulin secretion induced by three-day bed rest in sedentary subjects and endurance or strength trained athletes. J Gravit Physiol. 1998;5:P103-P104.
4. Stuart CA, Shangraw RE, Prince MJ, Peters EJ, Wolfe RR. Bed-rest-induced insulin resistance occurs primarily in muscle. Metabolism. 1988;37:802-806.
5. Yanagibori R, Suzuki Y, Kawakubo K, Makita Y, Gunji A. Carbohydrate and lipid metabolism after 20 days of bed rest. Acta Physiol Scand Suppl. 1994;616:51-57.
6. Mikines KJ, Dela F, Tronier B, Galbo H. Effect of 7 days of bed rest on dose-response relation between plasma glucose and insulin secretion. Am J Physiol. 1989;257(1, pt 1):E43-E48.
7. Biolo G, Ciocchi B, Stulle M, et al. Calorie restriction accelerates the catabolism of lean body mass during 2 wk of bed rest. Am J Clin Nutr. 2007;86:366-372.
8. Dorfman TA, Levine BD, Tillery T, et al. Cardiac atrophy in women following bed rest. J Appl Physiol. 2007;103:8-16.
9. Blanc S, Normand S, Pachiaudi C, Fortrat JO, Laville M, Gharib C. Fuel homeostasis during physical inactivity induced by bed rest. J Clin Endocrinol Metab. 2000;85:2223-2233.
10. Maloni JA, Margevicius SP, Damato EG. Multiple gestation: side effects of antepartum bed rest. Biol Res Nurs. 2006;8:115-128.
11. Thorell A, Nygren J, Ljungqvist O. Insulin resistance: a marker of surgical stress. Curr Opin Clin Nutr Metab Care. 1999;2:69-78.
12. Nygren J, Thorell A, Efendic S, Nair KS, Ljungqvist O. Site of insulin resistance after surgery: the contribution of hypocaloric nutrition and bed rest. Clin Sci (Lond). 1977;93:137-146.
13. Newby LK, Eisenstein EL, Califf RM, et al. Cost effectiveness of early discharge after uncomplicated acute myocardial infarction. N Engl J Med. 2000;342:749-755.
14. Clement S. Better glycemic control in the hospital: beneficial and feasible [published correction appears in Cleve Clin J Med. 2007;74:238]. Cleve Clin J Med. 2007;74:111-112, 114-120.
15. Vinik AI, Erbas T, Park TS, Nolan R, Pittenger GL. Platelet dysfunction in type 2 diabetes. Diabetes Care. 2001;24:1476-1485.
16. Lindeman RD, Romero LJ, Hundley R, et al. Prevalences of type 2 diabetes, the insulin resistance syndrome, and coronary heart disease in an elderly, biethnic population. Diabetes Care. 1998;21:959-966.
17. Skrha J, Haas T, Sindelka G, et al. Comparison of the insulin action parameters from hyperinsulinemic clamps with homeostasis model assessment and QUICKI indexes in subjects with different endocrine disorders. J Clin Endocrinol Metab. 2004;89:135-141.
18. Rabasa-Lhoret R, Bastard JP, Jan V, et al. Modified quantitative insulin sensitivity check index is better correlated to hyperinsulinemic glucose clamp than other fasting-based index of insulin sensitivity in different insulin-resistant states. J Clin Endocrinol Metab. 2003;88:4917-4923.
19. Katsuki A, Sumida Y, Gabazza EC, et al. QUICKI is useful for following improvements in insulin sensitivity after therapy in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab. 2002;87:2906-2908.
20. Chen H, Sullivan G, Quon MJ. Assessing the predictive accuracy of QUICKI as a surrogate index for insulin sensitivity using a calibration model. Diabetes. 2005;54:1914-1925.
21. Roberts WL, Moulton L, Law TC, et al. Evaluation of nine automated high-sensitivity C-reactive protein methods: implications for clinical and epidemiological applications. Part 2 [published correction appears in Clin Chem. 2001;47:980]. Clin Chem. 2001;47:418-425.
22. Moody MD, Van Arsdell SW, Murphy KP, Orencole SF, Burns C. Array-based ELISAs for high-throughput analysis of human cytokines. Biotechniques. 2001;31:186-190, 192-194.
23. Declerck PJ, Alessi MC, Verstreken M, Kruithof ED, Juhan-Vague I, Collen D. Measurement of plasminogen activator inhibitor 1 in biologic fluids with a murine monoclonal antibody-based enzyme-linked immunosorbent assay. Blood. 1988;71:220-225.
24. Geffken DF, Keating FG, Kennedy MH, Cornell ES, Bovill EG, Tracy RP. The measurement of fibrinogen in population-based research: studies on instrumentation and methodology. Arch Pathol Lab Med. 1994;118:1106-1109.
25. Bondar RJ, Mead DC. Evaluation of glucose-6-phosphate dehydrogenase from Leuconostoc mesenteroides in the hexokinase method for determining glucose in serum. Clin Chem. 1974;120:586-590.
26. Hardy RW, Cohn M, Konrad RJ. Automated chemiluminescent assay for C-peptide. J Clin Lab Anal. 2000;14:17-19.
27. Andersen L, Dinesen B, Jørgensen PN, Poulsen F, Røder ME. Enzyme immunoassay for intact human insulin in serum or plasma. Clin Chem. 1993;39:578-582.
28. Cuff DJ, Meneilly GS, Martin A, Ignaszewski A, Tildesley HD, Frohlich JJ. Effective exercise modality to reduce insulin resistance in women with type 2 diabetes. Diabetes Care. 2003;26:2977-2982.
29. Sigal RJ, Kenny GP, Wasserman DH, Castaneda-Sceppa C, White RD. Physical activity/exercise and type 2 diabetes: a consensus statement from the American Diabetes Association. Diabetes Care. 2006;29:1433-1438.
30. Campbell RK. Etiology and effect on outcomes of hyperglycemia in hospitalized patients. Am J Health Syst Pharm. 2007;64(10 suppl 6):S4-S8.